IRIS
ORANGER, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.694
EU - Europa 1.158
AS - Asia 566
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 5.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.693
CN - Cina 388
SE - Svezia 337
IT - Italia 336
UA - Ucraina 148
SG - Singapore 138
DE - Germania 136
FI - Finlandia 90
GB - Regno Unito 51
IN - India 26
IE - Irlanda 22
FR - Francia 20
BE - Belgio 7
CZ - Repubblica Ceca 7
IR - Iran 7
AU - Australia 3
KR - Corea 3
VN - Vietnam 3
AT - Austria 1
BO - Bolivia 1
CA - Canada 1
EU - Europa 1
HR - Croazia 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
Totale 5.423
Salva come PNG Salva come JPEG
Città #
Fairfield 401
Chandler 395
Jacksonville 355
Woodbridge 332
Nyköping 249
Houston 227
Bari 201
Ashburn 188
Cambridge 179
Ann Arbor 170
Seattle 155
Wilmington 133
Singapore 105
Roxbury 93
Lawrence 91
Nanjing 86
New York 64
Beijing 63
Des Moines 63
Boardman 54
Princeton 42
Inglewood 39
Dearborn 37
Brooklyn 32
San Diego 32
Shenyang 31
Nanchang 25
Los Angeles 23
Pune 23
Dublin 22
Santa Clara 21
London 18
Changsha 17
Hebei 17
Jiaxing 17
Munich 15
Noicattaro 15
Tianjin 14
Trani 14
Redwood City 12
Paris 10
Boydton 9
Guangzhou 9
Hefei 9
Orta Nova 9
Wuhan 9
Ardabil 7
Brno 7
Brussels 7
Falls Church 7
Helsinki 7
Kunming 7
Melito Di Napoli 7
Norwalk 7
Rome 7
Leawood 6
San Mateo 6
Bologna 5
Grumo Appula 5
Indiana 5
Jinan 5
Shanghai 5
Augusta 3
Dong Ket 3
Fuzhou 3
Kilburn 3
Nanning 3
Ningbo 3
Nürnberg 3
Quanzhou 3
Taizhou 3
Washington 3
Wuxi 3
Acton 2
Auburn Hills 2
Chiswick 2
Grottaglie 2
Heze 2
Mottola 2
Mumbai 2
Novi Ligure 2
Pieve di Cento 2
Qingdao 2
Roccapiemonte 2
San Francisco 2
Strasbourg 2
Turin 2
Xian 2
Zhengzhou 2
Agoura Hills 1
Ankara 1
Athis-mons 1
Bitritto 1
Brisbane 1
Cerignola 1
Chengdu 1
Chongqing 1
Clifton 1
Costa Mesa 1
Cutrofiano 1
Totale 4.301
Salva come PNG Salva come JPEG
Nome #
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 143
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α 129
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems 128
Sclerostin stimulates angiogenesis in human endothelial cells 112
TRAIL effect on osteoclast formation in physiological and pathological conditions 106
Osteogenic differentiation of dental follicle stem cells. 102
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 99
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 95
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 91
In vitro osteoclastogenesis and T-cell RANKL expression in multiple myeloma-bone disease at diagnosis and in the setting of frontline treatment 90
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 87
TRAIL is involved in human osteoclast apoptosis 86
Aortic valvular interstitial cells apoptosis and calcification is mediated by TNF-related apoptosis-inducing ligand 86
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 75
null 74
Alteration of the osteogenic properties of bone marrow stromal cells from multiple myeloma bone disease patients 72
The Role of LIGHT in Multiple Myeloma-Bone Disease 72
Elevati livelli sierici di Dkk1, antagonista del segnale di WNT in bambini obesi. 71
null 71
Osteoblasts display different responsiveness to TRAIL- induced apoptosis during their differentiation process 71
Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 70
Alteration of bone remodeling in multiple myeloma bone disease: role of sclerostin 68
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 68
Cellular mechanisms of multiple myeloma bone disease 67
THE ROLE OF LIGHT ON BONE REMODELING 67
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 66
Myeloma cells suppress osteoblasts through sclerostin secretion 66
null 63
T cells support osteoclastogenesis in an in vitro model derived from psoritic arthritis 63
Alterazione delle capacità osteogeniche in cellule stromali ottenute da midollo osseo di pazienti affetti da mieloma multiplo 62
Another link between bone and immune system: LIGHT 62
Dental pulp stem cells: osteogenic differentiation and genes expression 62
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 62
Altered osteogenic properties of bone marrow stromal cells from multiple myeloma patients 61
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis 60
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 59
Alterazione del rimodellamento osseo in soggetti in età pediatrica affetti da deficit di 21-idrossilasi (21-OHD): ruolo di DKK1 58
null 57
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 55
Alterazione del potenziale osteogenico in osteoblasti ottenuti da soggetti affetti da malattia parodontale: ruolo dei recettori apoptotici per TRAIL 55
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 55
Myeloma cells induce osteoblast suppression through sclerostin secretion 53
Failure of an in vitro model of osteoclastogenesis in human plasma cell leukaemia (PCL) 53
The effect of Irisin on bone cells in vivo and in vitro 53
Osteoclast apoptosis: Role of TRAIL and its receptors 52
Mechanism of Bone Disease in Prader-Willi Syndrome 52
Spontaneous osteoclastogenesis TNF-a and RANKL mediated in patients with Turner syndrome. 51
Sclerostin, produced by myeloma plasma cell, suppresses osteoblast activity 51
Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL 51
Soluble decoy receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 50
The role of the Wnt-signaling antagonist Sclerostin in the development of osteolytic lesions in multiple myeloma 49
No spontaneous osteoclast formation in an in vitro model derived from primary plasma cell leukemia 49
LIGHT: another link between bone and immune system 49
null 49
Osteogenic properties of human dental pulp stem cells 47
LIGHT: a new potential molecule involved in bone loss 46
Impairment of osteoblast diffeentiation and activity through sclerostin in multiple myeloma bone disease ??? 46
DcR3 involvement in multiple myeloma bone disease 45
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 45
Inflammatory Cells in Diffuse Large B Cell Lymphoma 45
Osteoclast formation in Multiple Myeloma bone disease patients: role of DcR3 44
DCR3 involvement in multiple myeloma bone disease 44
Formazione e sopravvivenza di osteoclasti in pazienti affetti da mieloma multiplo: ruolo di DcR3 43
Survival and formation of osteoclasts from multiple myeloma bone disease patients: role of decoy receptor 3 (DCR3) 43
Ridotta attività degli osteoblasti nel mieloma multiplo: ruolo della sclerostina 42
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 42
High serum levels of the WNT-signaling antagonist Dkk1 in children with 21-hydroxylase deficiency (21-OHD) 41
The role of the Wnt-signaling antagonist sclerostin in the development of osteolytic lesions in multiple myeloma 41
Circulating levels of cathepsin-k in multiple myeloma patients 41
null 41
Evaluation of serum levels of cathepsin k in multiple myeloma patients 40
High serum levels of the WNT-signaling antagonist Dkk1 in obese children 39
Inhibition of osteoclast apoptosis in multiple myeloma bone diseases: role of DCR3 39
Osteoclastogensi spontanea TNF-alpha e RANKL mediata in pazienti con Sindrome di Turner 37
Irisin and Secondary Osteoporosis in Humans 37
DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNFα up-regulation 36
Le cellule T supportano la formazione di osteoclasti in vitro in campioni di sangue periferico ottenuti da pazienti affetti da artrite psoriasica 36
Shedding LIGHT on bone cell differentiation and Multiple Myeloma-bone disease 36
Osteoblast apoptosis in periodontal disease: role of TRAIL 36
TRAIL effect on osteoclast formation in multiple myeloma-bone disease 35
IN VITRO EVALUATION OF OSTEOGENIC PROPERTIES OF HUMAN DENTAL PULP STEM CELLS 35
Formazione di osteoclasti in un modello in vitro derivato da pazienti affetti da mieloma multiplo: interazione OPG/TRAIL 33
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 33
Decoy Receptor 3 DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNF-ALPHA up-regulation 32
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 32
Ruolo di LIGHT (tnfsf14) nella malattia ossea associata al mieloma multiplo 30
ROLE OF DCR3 ON OSTEOCLAST FORMATION IN MULTIPLE MYELOMA BONE DISEASE PATIENTS 30
Bone Cells 29
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 28
Detection of the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 27
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 27
Ridotta attività degli osteoclasti nel mieloma multiplo: ruolo di sclerostina 26
Osteoclast formation and survival in multiple myeloma bone disease patients: role of DcR3 26
Suppressed osteoblast differentiation and activity in multiple myeloma bone disease: role of sclerostin 26
The role of light (TNFSF14) on bone remodeling 25
The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of solubile decoy receptor 3 24
Role of DcR3 on osteoclast formation in multiple myeloma bone disease patients. 21
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 21
Solubile decoy receptor 3 (DCR3) modulates the survival of osteoclasts derived from patients with multiple myeloma lytic bone disease 20
DcR3 involvement in multiple myeloma bone disease 19
Totale 5.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020762 0 0 0 56 92 73 133 77 120 60 129 22
2020/2021814 92 27 78 22 89 48 86 52 110 112 65 33
2021/2022789 23 107 5 32 26 49 28 35 125 40 132 187
2022/20231.152 165 125 65 85 141 135 21 132 228 5 20 30
2023/2024432 44 85 14 27 37 115 8 4 1 30 25 42
2024/2025304 128 27 141 8 0 0 0 0 0 0 0 0
Totale 5.580